Multicenter Retrospective Analysis of the Effectiveness and Safety of Rituximab in Korean Patients with Refractory Systemic Lupus Erythematosus

Objective. Although two recent randomized placebo-controlled trials of rituximab (RTX) failed to demonstrate efficacy in systemic lupus erythematosus (SLE), clinicians continue to use off-label RTX for cases refractory to current treatments. We evaluated the effectiveness and safety of rituximab for...

Descripción completa

Detalles Bibliográficos
Autores principales: Bang, So-Young, Lee, Chang Keun, Kang, Young Mo, Kim, Hyoun-Ah, Suh, Chang-Hee, Chung, Won Tae, Park, Yong-Beom, Choe, Jung-Yoon, Kim, Tae-Jong, Park, Yong-Wook, Yoo, Dae-Hyun, Bae, Sang-Cheol, Lee, Hye-Soon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3523406/
https://www.ncbi.nlm.nih.gov/pubmed/23304457
http://dx.doi.org/10.1155/2012/565039

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3523406/
https://www.ncbi.nlm.nih.gov/pubmed/23304457
http://dx.doi.org/10.1155/2012/565039

Ejemplares similares